ADARx Pharmaceuticals website screenshot

ADARx Pharmaceuticals

ADARx Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered at 5871 Oberlin Drive, San Diego, California, founded in 2019 and developing next-generation RNA therapeutics intended to control the expression of specific disease drivers with highly selective RNA-targeted medicines. Its proprietary platform spans RNA interference, RNA editing and targeted oligonucleotide delivery, engineered around compact, modular constructs the company says extend reach beyond the liver. The clinical pipeline is led by ADX-324 (onvuzosiran), an siRNA against prekallikrein now in the Phase 3 STOP-HAE study in hereditary angioedema, and ADX-038 (agazisiran), an siRNA against complement factor B in Phase 2 for IgA nephropathy and C3 glomerulopathy, geographic atrophy and paroxysmal nocturnal hemoglobinuria; earlier programmes include ADX-626 (factor XI, thrombosis), ADX-077 (obesity) and ADX-199 (amyloid-beta precursor protein, neurodegeneration), plus undisclosed extrahepatic CNS, immunology and oncology work. The company closed an oversubscribed 200 million dollar Series C in August 2023 co-led by Bain Capital Life Sciences and TCGX, and entered a collaboration and license option agreement with AbbVie in May 2025. ADARx runs no developer program and publishes no product API, no developer portal and no API documentation; the only machine-readable surfaces reachable without credentials are the WordPress REST content APIs behind www.adarx.com and stophae.com, both catalogued here.

ADARx Pharmaceuticals publishes 8 APIs on the APIs.io network, including Clinics API, Content API, Embed API, and 5 more. Tagged areas include Company, biotechnology, biopharmaceuticals, rna-therapeutics, and sirna.

The ADARx Pharmaceuticals catalog on APIs.io includes 1 JSON-LD context.

ADARx Pharmaceuticals’ developer surface includes product news, support, authentication, and 30 more developer resources.

32.1/100 thin ▬ flat Agent 33/100 agent aware Full breakdown ↓
scored 2026-08-12 · rubric v0.11.0
8 APIs
Companybiotechnologybiopharmaceuticalsrna-therapeuticssirnarna-editingclinical-trialsrare-diseasedrug-developmentlife-sciencessan-diegocontent-api

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-12 · rubric v0.11.0
Composite quality — 32.1/100 · thin
Contract Quality 12.9 / 21
Developer Ergonomics 2.9 / 17
Commercial Clarity 3.6 / 17
Operational Transparency 0.0 / 11
Governance 1.2 / 10
Discoverability 6.9 / 9
Regulatory Posture 4.7 / 15
Agent readiness — 33/100 · agent aware
Machine-Readable Contract 18 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 10 / 10
Idempotency 0 / 9
Stable Error Semantics 8 / 8
Request/Response Examples 7 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 5 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/adarx-pharmaceuticals: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

APIs 8

Individual APIs this provider publishes, each with its own machine-readable definition.

ADARx Pharmaceuticals Clinics API

The STOP-HAE trial-site (clinic) registry.

ADARx Pharmaceuticals Content API

Press releases, publications and corporate pages.

ADARx Pharmaceuticals Embed API

oEmbed provider and SEO head rendering.

ADARx Pharmaceuticals Index API

Route discovery and site identity.

ADARx Pharmaceuticals Media API

The site media library.

ADARx Pharmaceuticals People API

Content authors registered on the site.

ADARx Pharmaceuticals Search API

Cross-content search.

ADARx Pharmaceuticals Taxonomy API

Categories, tags, taxonomies and post statuses.

Scroll for all 8

Semantic Vocabularies 1

JSON-LD contexts and semantic vocabularies used across these APIs.

Adarx Pharmaceuticals Website Context

0 classes · 0 properties

JSON-LD

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Adarx Pharmaceuticals Authentication

http · 2 schemes

SECURITY

Adarx Pharmaceuticals Domain Security

TLSv1.3 · DNSSEC · DMARC

SECURITY

Resources

Get Started 1

Portal, sign-up, and the first successful call

Agent Surfaces 3

MCP servers, agent skills, and machine-readable catalogs

Design & Contract 6

Pagination, idempotency, versioning, errors, and events

Access & Security 2

Authentication, authorization, and security posture

Operate 2

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 7

The organization behind the API

Scroll for all 7

Other 10

Properties that don't map to a standard resource type

Scroll for all 10

Source (apis.yml)

apis.yml Raw ↑
aid: adarx-pharmaceuticals
name: ADARx Pharmaceuticals
description: ADARx Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered at 5871 Oberlin Drive, San
  Diego, California, founded in 2019 and developing next-generation RNA therapeutics intended to control the expression of
  specific disease drivers with highly selective RNA-targeted medicines. Its proprietary platform spans RNA interference,
  RNA editing and targeted oligonucleotide delivery, engineered around compact, modular constructs the company says extend
  reach beyond the liver. The clinical pipeline is led by ADX-324 (onvuzosiran), an siRNA against prekallikrein now in the
  Phase 3 STOP-HAE study in hereditary angioedema, and ADX-038 (agazisiran), an siRNA against complement factor B in Phase
  2 for IgA nephropathy and C3 glomerulopathy, geographic atrophy and paroxysmal nocturnal hemoglobinuria; earlier programmes
  include ADX-626 (factor XI, thrombosis), ADX-077 (obesity) and ADX-199 (amyloid-beta precursor protein, neurodegeneration),
  plus undisclosed extrahepatic CNS, immunology and oncology work. The company closed an oversubscribed 200 million dollar
  Series C in August 2023 co-led by Bain Capital Life Sciences and TCGX, and entered a collaboration and license option agreement
  with AbbVie in May 2025. ADARx runs no developer program and publishes no product API, no developer portal and no API documentation;
  the only machine-readable surfaces reachable without credentials are the WordPress REST content APIs behind www.adarx.com
  and stophae.com, both catalogued here.
image: https://www.adarx.com/wp-content/uploads/2024/11/adarx-logo.png
url: https://raw.githubusercontent.com/api-evangelist/adarx-pharmaceuticals/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- biotechnology
- biopharmaceuticals
- rna-therapeutics
- sirna
- rna-editing
- clinical-trials
- rare-disease
- drug-development
- life-sciences
- san-diego
- content-api
apis:
- aid: adarx-pharmaceuticals:adarx-pharmaceuticals-clinics-api
  name: ADARx Pharmaceuticals Clinics API
  description: The STOP-HAE trial-site (clinic) registry.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.adarx.com/wp-json
  tags:
  - clinics
  properties:
  - type: OpenAPI
    url: openapi/adarx-pharmaceuticals-clinics-api-openapi.yml
  - type: Authentication
    url: authentication/adarx-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/adarx-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/adarx-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/adarx-pharmaceuticals-data-model.yml
  - type: JSONLD
    url: json-ld/adarx-pharmaceuticals-json-ld.yml
- aid: adarx-pharmaceuticals:adarx-pharmaceuticals-content-api
  name: ADARx Pharmaceuticals Content API
  description: Press releases, publications and corporate pages.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.adarx.com/wp-json
  tags:
  - content
  properties:
  - type: OpenAPI
    url: openapi/adarx-pharmaceuticals-content-api-openapi.yml
  - type: Authentication
    url: authentication/adarx-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/adarx-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/adarx-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/adarx-pharmaceuticals-data-model.yml
  - type: JSONLD
    url: json-ld/adarx-pharmaceuticals-json-ld.yml
- aid: adarx-pharmaceuticals:adarx-pharmaceuticals-embed-api
  name: ADARx Pharmaceuticals Embed API
  description: oEmbed provider and SEO head rendering.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.adarx.com/wp-json
  tags:
  - embed
  properties:
  - type: OpenAPI
    url: openapi/adarx-pharmaceuticals-embed-api-openapi.yml
  - type: Authentication
    url: authentication/adarx-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/adarx-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/adarx-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/adarx-pharmaceuticals-data-model.yml
  - type: JSONLD
    url: json-ld/adarx-pharmaceuticals-json-ld.yml
- aid: adarx-pharmaceuticals:adarx-pharmaceuticals-index-api
  name: ADARx Pharmaceuticals Index API
  description: Route discovery and site identity.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.adarx.com/wp-json
  tags:
  - index
  properties:
  - type: OpenAPI
    url: openapi/adarx-pharmaceuticals-index-api-openapi.yml
  - type: Authentication
    url: authentication/adarx-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/adarx-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/adarx-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/adarx-pharmaceuticals-data-model.yml
  - type: JSONLD
    url: json-ld/adarx-pharmaceuticals-json-ld.yml
- aid: adarx-pharmaceuticals:adarx-pharmaceuticals-media-api
  name: ADARx Pharmaceuticals Media API
  description: The site media library.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.adarx.com/wp-json
  tags:
  - media
  properties:
  - type: OpenAPI
    url: openapi/adarx-pharmaceuticals-media-api-openapi.yml
  - type: Authentication
    url: authentication/adarx-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/adarx-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/adarx-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/adarx-pharmaceuticals-data-model.yml
  - type: JSONLD
    url: json-ld/adarx-pharmaceuticals-json-ld.yml
- aid: adarx-pharmaceuticals:adarx-pharmaceuticals-people-api
  name: ADARx Pharmaceuticals People API
  description: Content authors registered on the site.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.adarx.com/wp-json
  tags:
  - people
  properties:
  - type: OpenAPI
    url: openapi/adarx-pharmaceuticals-people-api-openapi.yml
  - type: Authentication
    url: authentication/adarx-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/adarx-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/adarx-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/adarx-pharmaceuticals-data-model.yml
  - type: JSONLD
    url: json-ld/adarx-pharmaceuticals-json-ld.yml
- aid: adarx-pharmaceuticals:adarx-pharmaceuticals-search-api
  name: ADARx Pharmaceuticals Search API
  description: Cross-content search.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.adarx.com/wp-json
  tags:
  - search
  properties:
  - type: OpenAPI
    url: openapi/adarx-pharmaceuticals-search-api-openapi.yml
  - type: Authentication
    url: authentication/adarx-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/adarx-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/adarx-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/adarx-pharmaceuticals-data-model.yml
  - type: JSONLD
    url: json-ld/adarx-pharmaceuticals-json-ld.yml
- aid: adarx-pharmaceuticals:adarx-pharmaceuticals-taxonomy-api
  name: ADARx Pharmaceuticals Taxonomy API
  description: Categories, tags, taxonomies and post statuses.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.adarx.com/wp-json
  tags:
  - taxonomy
  properties:
  - type: OpenAPI
    url: openapi/adarx-pharmaceuticals-taxonomy-api-openapi.yml
  - type: Authentication
    url: authentication/adarx-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/adarx-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/adarx-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/adarx-pharmaceuticals-data-model.yml
  - type: JSONLD
    url: json-ld/adarx-pharmaceuticals-json-ld.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Overlay
  url: overlays/adarx-pharmaceuticals-content-overlay.yaml
- type: Website
  url: https://www.adarx.com/
- type: About
  url: https://www.adarx.com/company/company-overview/
- type: Company
  url: https://www.adarx.com/company/
- type: Team
  url: https://www.adarx.com/company/team/
- type: Investors
  url: https://www.adarx.com/company/investors/
- type: Science
  url: https://www.adarx.com/science/science-overview/
- type: Technology
  url: https://www.adarx.com/science/technology/
- type: Pipeline
  url: https://www.adarx.com/pipeline/
- type: Publications
  url: https://www.adarx.com/science/publications/
- type: Patients
  url: https://www.adarx.com/patients/
- type: ClinicalTrials
  url: https://stophae.com/
- type: News
  url: https://www.adarx.com/news/
- type: BlogRSS
  url: https://www.adarx.com/feed/
- type: Careers
  url: https://www.adarx.com/careers/
- type: Contact
  url: https://www.adarx.com/contact/
- type: Support
  url: https://www.adarx.com/contact/
- type: TermsOfService
  url: https://www.adarx.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.adarx.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/adarx-pharmaceuticals-inc/
- type: Sitemap
  url: https://www.adarx.com/sitemap_index.xml
- type: SecondaryMarket
  url: https://www.nasdaqprivatemarket.com/
- type: Authentication
  url: authentication/adarx-pharmaceuticals-authentication.yml
- type: Conventions
  url: conventions/adarx-pharmaceuticals-conventions.yml
- type: Conformance
  url: conformance/adarx-pharmaceuticals-conformance.yml
- type: ErrorCatalog
  url: errors/adarx-pharmaceuticals-problem-types.yml
- type: Lifecycle
  url: lifecycle/adarx-pharmaceuticals-lifecycle.yml
- type: DataModel
  url: data-model/adarx-pharmaceuticals-data-model.yml
- type: JSONLD
  url: json-ld/adarx-pharmaceuticals-json-ld.yml
- type: WellKnown
  url: well-known/adarx-pharmaceuticals-well-known.yml
- type: DomainSecurity
  url: security/adarx-pharmaceuticals-domain-security.yml
- type: LLMsTxt
  url: llms/adarx-pharmaceuticals-llms.txt
- type: AgentSkill
  url: skills/_index.yml
x-enrichment:
  date: '2026-08-06'
  status: enriched
  artifacts_added: 20
  pass: local-v1